Insurance

nib offers genetic testing

Thursday 21st of March 2019

In a release, the insurer said women with ovarian cancer were able to access testing in the private health system to work out the best course of treatment.

Patients with a BRCA mutation gene are likely to benefit from the addition of a treatment called PARP inhibitors.

Chief executive Rob Hennin said genomic profiling played an increasing role in the treatment and management of...

Want to read the full article?
Click the button below to subscribe and will have unlimited access to full article and all other articles on the site.